Megan Boston serves as Executive at Benitec Biopharma Inc., where they oversee executive responsibilities. Since joining the company, Megan Boston has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Aug 11, 2023 involved purchasing 25,907 shares valued at $0.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Aug 11, 2023 | BNTC | $0 | Purchase | 25,907 | $N/A | Discretionary |
Megan Boston currently holds 25,907 shares of Benitec Biopharma Inc. (BNTC), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Megan Boston has been a net neutral trader of BNTC stock. They have purchased $0 and sold $0 worth of shares.
Megan Boston's most recent insider trade was on Aug 11, 2023, when they purchased 25,907 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted